Inhaled AP301 for treatment of pulmonary edema in mechanically ventilated patients with acute respiratory distress syndrome: a phase IIa randomized placebo-controlled trial.
about
Cytokine-Ion Channel Interactions in Pulmonary Inflammation.Listeriolysin O Causes ENaC Dysfunction in Human Airway Epithelial Cells.Recent advances in understanding acute respiratory distress syndrome.Multifaceted Role of Pneumolysin in the Pathogenesis of Myocardial Injury in Community-Acquired Pneumonia.Adjunctive therapies during veno-venous extracorporeal membrane oxygenation.Editorial: Cytokine-Ion Channel Interactions in Pulmonary Inflammation
P2860
Inhaled AP301 for treatment of pulmonary edema in mechanically ventilated patients with acute respiratory distress syndrome: a phase IIa randomized placebo-controlled trial.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Inhaled AP301 for treatment of ...... ized placebo-controlled trial.
@en
type
label
Inhaled AP301 for treatment of ...... ized placebo-controlled trial.
@en
prefLabel
Inhaled AP301 for treatment of ...... ized placebo-controlled trial.
@en
P2093
P2860
P50
P1433
P1476
Inhaled AP301 for treatment of ...... ized placebo-controlled trial.
@en
P2093
Adrien Croizé
Klaus Markstaller
Robert Hermann
Roman Ullrich
Stefan Boehme
P2860
P2888
P356
10.1186/S13054-017-1795-X
P577
2017-07-27T00:00:00Z